RecruitingNCT06855004
Prospective Cohort of Patients With Fibrosing Interstitial Lung Disease Admitted for Acute Respiratory Failure
Studying Interstitial lung disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Nathan EBSTEIN, DrAssistance Publique - Hôpitaux de Paris
- Enrollment
- 250 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2030
Study locations (1)
- Hôpital Avicenne APHP Réanimation médico-chirurgicale, Bobigny, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06855004 on ClinicalTrials.govOther trials for Interstitial lung disease
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07398287Efficacy of L-menthol on Breathlessness in Interstitial Lung DiseaseRegion Skane
- RECRUITINGNANCT07283081Impact of Capillaroscopy in the Investigation of Diffuse Interstitial PneumoniasUniversity Hospital, Bordeaux
- RECRUITINGNANCT07254338Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension TreatmentHospices Civils de Lyon
- RECRUITINGPHASE1NCT07372989Nebulized Human Amniotic Fluid in Patients With Interstitial Lung DiseaseMaule Stem Cell Research Institute, Inc.
- RECRUITINGPHASE1NCT06992661A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung DiseaseRuijin Hospital
- RECRUITINGNANCT07301697Safety and Performance Profile of Cryobiopsy in Bronchial EndoscopyUniversity Hospital, Strasbourg, France
- RECRUITINGNANCT07300696Functional MRI for Monitoring Progression and Assessing Trends in ILDUniversity Hospital Heidelberg
- RECRUITINGPHASE3NCT06806592A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic DiseasesBoehringer Ingelheim